David Rafei-Shamsabadi
7PUBLICATIONS
13CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (7)
Sort by Publication Date:
|Jan 26, 2024
Epidermolysis-Bullosa-Associated Squamous Cell Carcinomas Support an Immunosuppressive Tumor Microenvironment: Prospects for Immunotherapy.David Rafei-Shamsabadi, Lena Scholten, Sisi Lu
|Feb 15, 2022
Additive Intralesional Interleukin-2 Improves Progression-Free Survival in a Distinct Subgroup of Melanoma Patients with Prior Progression under Immunotherapy.David Rafei-Shamsabadi, Saskia Lehr, Max Behrens
|Oct 23, 2020
Immune checkpoint inhibition therapy for advanced skin cancer in patients with concomitant hematological malignancy: a retrospective multicenter DeCOG study of 84 patients.Ulrike Leiter, Carmen Loquai, Lydia Reinhardt
|Mar 30, 2020
Combined immunotherapy with nivolumab and ipilimumab with and without local therapy in patients with melanoma brain metastasis: a DeCOG* study in 380 patients.Teresa Amaral, Felix Kiecker, Sarah Schaefer
|Aug 19, 2019
Successful combination therapy of systemic checkpoint inhibitors and intralesional interleukin-2 in patients with metastatic melanoma with primary therapeutic resistance to checkpoint inhibitors alone.David Rafei-Shamsabadi, Saskia Lehr, Dagmar von Bubnoff
Pageof 2
Frequent Collaborators
3 joint publications
Frank Meiss
1 joint publications
A Schwieger-Briel
1 joint publications
H Schumann
1 joint publications
A Reimer-Taschenbrecker
1 joint publications
C Has
1 joint publications
Teresa Amaral
1 joint publications
Thilo Gambichler
1 joint publications
Michael Weichenthal
1 joint publications
Jürgen Christian Becker
1 joint publications
Selma Ugurel
